Patrick Hall Lizotte

机构：Harvard University, Dana-Farber Cancer Institute · ORCID：0000-0001-9510-0036

发表论文 245 篇 · 总被引 9581 次 · h-index 35

代表论文

• Eradicating Drug-tolerant Persister Cells in EGFR- Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy (2025 · Cancer Discovery · 被引 29)
• Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer (2026 · Cancer Cell · 被引 12)
• Circulating T-cell receptor repertoire for cancer early detection (2025 · npj Precision Oncology · 被引 12)
• Phase I Clinical Trial of the Bifunctional EGFR/TGF-β Fusion Protein Ficerafusp Alfa (BCA101) Alone and in Combination with Pembrolizumab for Advanced Solid Tumors (2025 · Clinical Cancer Research · 被引 7)
• EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapy (2026 · JCI Insight · 被引 4)
• Drug-tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanisms (2025 · Cell Death and Differentiation · 被引 4)